|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,687.80 INR | +0.02% |
|
+0.28% | -10.53% |
| 09:32am | India's Sun Pharma names Kirti Ganorkar as managing director | RE |
| 09:32am | India's Sun Pharma names Kirti Ganorkar as managing director | RE |
| Capitalization | 4,049B 47.28B 40.85B 38.46B 34.8B 64.38B 72.5B 447B 174B 1,860B 177B 174B 6,795B | P/E ratio 2025 |
38x | P/E ratio 2026 * | 32.8x |
|---|---|---|---|---|---|
| Enterprise value | 3,831B 44.74B 38.65B 36.39B 32.93B 60.92B 68.61B 423B 165B 1,760B 168B 164B 6,430B | EV / Sales 2025 |
7.48x | EV / Sales 2026 * | 6.56x |
| Free-Float |
44.9% | Yield 2025 |
0.92% | Yield 2026 * | 0.92% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sun Pharmaceutical Industries Ltd.
More recommendations
More press releases
More news
| 1 day | +0.02% | ||
| 1 week | +0.51% | ||
| Current month | +0.61% | ||
| 1 month | -0.72% | ||
| 3 months | +0.26% | ||
| 6 months | -6.93% | ||
| Current year | -10.53% |
| 1 week | 1,661.1 |  | 1,727.5 |
| 1 month | 1,636.6 | | 1,765 |
| Current year | 1,553.05 | | 1,896 |
| 1 year | 1,460.9 | | 1,960.35 |
| 3 years | 789.9 | | 1,960.35 |
| 5 years | 452.25 | | 1,960.35 |
| 10 years | 312 | | 1,960.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 69 | 1982-12-31 | |
| Director of Finance/CFO | - | 2017-06-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | - | |
| Director/Board Member | 68 | 1993-12-31 | |
| Director/Board Member | 72 | 2018-05-24 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.02% | +0.51% | +11.72% | +103.47% | 47.28B | ||
| -1.89% | +6.98% | +13.88% | +62.69% | 27.15B | ||
| -0.86% | -2.95% | +32.75% | - | 22.86B | ||
| +0.16% | +0.07% | -2.55% | +57.65% | 14.17B | ||
| -0.39% | +1.54% | -10.60% | +177.17% | 11.5B | ||
| +4.47% | +16.34% | +94.51% | +108.26% | 8.42B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| +0.27% | +1.35% | +37.73% | +99.15% | 6.65B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +1.85% | +5.01% | +36.34% | +344.83% | 5.4B | ||
| Average | +0.37% | +2.70% | +26.72% | +136.18% | 15.6B | |
| Weighted average by Cap. | -0.14% | +2.32% | +19.28% | +106.84% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 527B 6.16B 5.32B 5.01B 4.53B 8.38B 9.44B 58.18B 22.72B 242B 23.1B 22.61B 885B | 572B 6.68B 5.77B 5.43B 4.92B 9.1B 10.25B 63.14B 24.65B 263B 25.06B 24.54B 960B |
| Net income | 117B 1.37B 1.18B 1.11B 1.01B 1.86B 2.1B 12.91B 5.04B 53.75B 5.13B 5.02B 196B | 124B 1.44B 1.25B 1.17B 1.06B 1.97B 2.21B 13.64B 5.32B 56.78B 5.41B 5.3B 207B |
| Net Debt | -218B -2.54B -2.2B -2.07B -1.87B -3.46B -3.9B -24.01B -9.38B -99.97B -9.53B -9.33B -365B | -297B -3.46B -2.99B -2.82B -2.55B -4.72B -5.31B -32.73B -12.78B -136B -12.99B -12.72B -498B |
More financial data
* Estimated data
Employees
43,000
Sector
Pharmaceuticals
Calendar
07-06
- Final dividend
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-13 | 1,687.80 ₹ | +0.02% | 2,404,272 |
| 25-06-12 | 1,687.40 ₹ | -0.19% | 3,588,365 |
| 25-06-11 | 1,690.60 ₹ | +0.11% | 1,999,978 |
| 25-06-10 | 1,688.80 ₹ | -0.33% | 2,369,135 |
| 25-06-09 | 1,694.40 ₹ | +0.91% | 2,589,656 |
Delayed Quote NSE India S.E., June 13, 2025 at 07:49 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,687.40INR
Average target price
1,981.44INR
Spread / Average Target
+17.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition